136 related articles for article (PubMed ID: 21897064)
1. [Current treatment strategies with novel agents for multiple myeloma].
Tokuhira M
Rinsho Ketsueki; 2011 Aug; 52(8):587-602. PubMed ID: 21897064
[No Abstract] [Full Text] [Related]
2. Multiple myeloma.
Kyle RA; Rajkumar SV
N Engl J Med; 2004 Oct; 351(18):1860-73. PubMed ID: 15509819
[No Abstract] [Full Text] [Related]
3. [Thalidomide treatment in multiple myeloma].
Hattori Y
Rinsho Ketsueki; 2003 May; 44(5):302-12. PubMed ID: 12822404
[No Abstract] [Full Text] [Related]
4. [Update on treatment of multiple myeloma: including myeloma kidney and molecular targeting drugs].
Kawada H; Arima N
Nihon Jinzo Gakkai Shi; 2012; 54(5):586-92. PubMed ID: 22991837
[No Abstract] [Full Text] [Related]
5. [It is not necessary to use novel agents to all patients with newly diagnosed myeloma as an initial therapy].
Takamatsu Y
Rinsho Ketsueki; 2012 Jun; 53(6):587-93. PubMed ID: 22790633
[No Abstract] [Full Text] [Related]
6. New drugs for multiple myeloma.
Anderson KC
Clin Adv Hematol Oncol; 2006 Aug; 4(8):592-4. PubMed ID: 17099617
[No Abstract] [Full Text] [Related]
7. Treatment of multiple myeloma in the targeted therapy era.
Saad AA; Sharma M; Higa GM
Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of MDS, multiple myeloma, and CLL.
Snively A
ONS Connect; 2007; 22(8 Suppl):55-6. PubMed ID: 17824566
[No Abstract] [Full Text] [Related]
9. [Development and clinical application of novel proteasome inhibitors].
Iida S
Rinsho Ketsueki; 2012 Apr; 53(4):417-25. PubMed ID: 22687975
[No Abstract] [Full Text] [Related]
10. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
[TBL] [Abstract][Full Text] [Related]
11. [Treatment for multiple myeloma: current status and future strategy in Japan].
Iida S
Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
[No Abstract] [Full Text] [Related]
12. [Multiple myeloma -- therapy].
Jung W; Zettl F; Schroers R
Dtsch Med Wochenschr; 2005 Feb; 130(6):283-6; quiz 287-90. PubMed ID: 15692903
[No Abstract] [Full Text] [Related]
13. Management of older patients with multiple myeloma.
Gay F; Palumbo A
Blood Rev; 2011 Mar; 25(2):65-73. PubMed ID: 21295387
[TBL] [Abstract][Full Text] [Related]
14. [New strategy for the treatment of multiple myeloma].
Murakami H
Rinsho Ketsueki; 2005 Dec; 46(12):1263-72. PubMed ID: 16447798
[No Abstract] [Full Text] [Related]
15. Novel agents to improve outcome of allogeneic transplantation for patients with multiple myeloma.
Kortüm M; Knop S; Einsele H
Future Oncol; 2011 Jan; 7(1):135-43. PubMed ID: 21174544
[TBL] [Abstract][Full Text] [Related]
16. Allografting or autografting for myeloma.
van Rhee F; Crowley J; Barlogie B
N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17582078
[No Abstract] [Full Text] [Related]
17. [Recent progress in diagnosis of and therapy for multiple myeloma].
Okamoto S
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1922-31. PubMed ID: 17037337
[No Abstract] [Full Text] [Related]
18. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
19. [Current treatment strategies for multiple myeloma].
Mey UJ
Ther Umsch; 2010 Oct; 67(10):527-35. PubMed ID: 20886459
[TBL] [Abstract][Full Text] [Related]
20. [Supportive care in multiple myeloma for continuing anti-myeloma therapies].
Shibayama H
Rinsho Ketsueki; 2014 Oct; 55(10):1999-2004. PubMed ID: 25297765
[No Abstract] [Full Text] [Related]
[Next] [New Search]